LABU
$137.60
Direxion Daily S&P Biotech Bull 3X Shares
ENDING SOONFirst 100 Only
Help Us Build Premium ETF Tools
4 quick questions • Get LIFETIME free access
Worth $2,400→ FREE
Explore sections
Top 10 Holdings
Largest positions representing 18.5% of the portfolio
18.5%
of portfolio
Loading chart...
- Alnylam Pharmaceuticals Inc2.24%
- Halozyme Therapeutics Inc1.90%
- Insmed Inc1.87%
- Incyte Corp1.86%
- Moderna Inc1.82%
- Regeneron Pharmaceuticals Inc1.80%
- Neurocrine Biosciences Inc1.76%
- Gilead Sciences Inc1.76%
- BioMarin Pharmaceutical Inc1.73%
- Amgen Inc1.73%
| Rank | Company | Ticker | Sector | Weight (%) |
|---|---|---|---|---|
1 | Alnylam Pharmaceuticals Inc | ALNY | Health Care | 2.24% |
2 | Halozyme Therapeutics Inc | HALO | Health Care | 1.90% |
3 | Insmed Inc | IM8N | Health Care | 1.87% |
4 | Incyte Corp | INCY | Health Care | 1.86% |
5 | Moderna Inc | MRNA | Health Care | 1.82% |
6 | Regeneron Pharmaceuticals Inc | REGN | Health Care | 1.80% |
7 | Neurocrine Biosciences Inc | NBIX | Health Care | 1.76% |
8 | Gilead Sciences Inc | GILD | Health Care | 1.76% |
9 | BioMarin Pharmaceutical Inc | BMRN | Health Care | 1.73% |
10 | Amgen Inc | AMGN | Health Care | 1.73% |
Help Us Improve ETF Tools
Share your feedback and get early access to new features
Quick 2-minute survey→ FREE